Polyglutamine Disorders

Nonfiction, Health & Well Being, Medical, Specialties, Internal Medicine, Neuroscience, Neurology, Science & Nature, Science
Cover of the book Polyglutamine Disorders by , Springer International Publishing
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: ISBN: 9783319717791
Publisher: Springer International Publishing Publication: February 9, 2018
Imprint: Springer Language: English
Author:
ISBN: 9783319717791
Publisher: Springer International Publishing
Publication: February 9, 2018
Imprint: Springer
Language: English

This book provides a cutting-edge review of polyglutamine disorders. It primarily focuses on two main aspects: (1) the mechanisms underlying the pathologies’ development and progression, and (2) the therapeutic strategies that are currently being explored to stop or delay disease progression. 

Polyglutamine (polyQ) disorders are a group of inherited neurodegenerative diseases with a fatal outcome that are caused by an abnormal expansion of a coding trinucleotide repeat (CAG), which is then translated in an abnormal protein with an elongated glutamine tract (Q). To date, nine polyQ disorders have been identified and described: dentatorubral-pallidoluysian atrophy (DRPLA); Huntington’s disease (HD); spinal–bulbar muscular atrophy (SBMA); and six spinocerebellar ataxias (SCA 1, 2, 3, 6, 7, and 17).

The genetic basis of polyQ disorders is well established and described, and despite important advances that have opened up the possibility of generating genetic models of the disease, the mechanisms that cause neuronal degeneration are still largely unknown and there is currently no treatment available for these disorders. Further, it is believed that the different polyQ may share some mechanisms and pathways contributing to neurodegeneration and disease progression.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

This book provides a cutting-edge review of polyglutamine disorders. It primarily focuses on two main aspects: (1) the mechanisms underlying the pathologies’ development and progression, and (2) the therapeutic strategies that are currently being explored to stop or delay disease progression. 

Polyglutamine (polyQ) disorders are a group of inherited neurodegenerative diseases with a fatal outcome that are caused by an abnormal expansion of a coding trinucleotide repeat (CAG), which is then translated in an abnormal protein with an elongated glutamine tract (Q). To date, nine polyQ disorders have been identified and described: dentatorubral-pallidoluysian atrophy (DRPLA); Huntington’s disease (HD); spinal–bulbar muscular atrophy (SBMA); and six spinocerebellar ataxias (SCA 1, 2, 3, 6, 7, and 17).

The genetic basis of polyQ disorders is well established and described, and despite important advances that have opened up the possibility of generating genetic models of the disease, the mechanisms that cause neuronal degeneration are still largely unknown and there is currently no treatment available for these disorders. Further, it is believed that the different polyQ may share some mechanisms and pathways contributing to neurodegeneration and disease progression.

More books from Springer International Publishing

Cover of the book Efficient Sensor Interfaces, Advanced Amplifiers and Low Power RF Systems by
Cover of the book The Ecosystems Revolution by
Cover of the book Quantitative Evaluation of Systems by
Cover of the book Penalty, Shrinkage and Pretest Strategies by
Cover of the book Forging Connections between Computational Mathematics and Computational Geometry by
Cover of the book ‘Now I Know’: Five Centuries of Aqedah Exegesis by
Cover of the book Entrepreneurship and Structural Change in Dynamic Territories by
Cover of the book A Feminist Companion to the Posthumanities by
Cover of the book Resistance to Aromatase Inhibitors in Breast Cancer by
Cover of the book Engineering Mineralized and Load Bearing Tissues by
Cover of the book Nonlinear Economic Dynamics and Financial Modelling by
Cover of the book The Sol-to-Gel Transition by
Cover of the book Interactive Governance for Small-Scale Fisheries by
Cover of the book Clinical Cases in Heart Failure by
Cover of the book Ovulation Induction and Controlled Ovarian Stimulation by
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy